Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Indivior ( (GB:INDV) ) has issued an update.
Indivior PLC announced a change in its major holdings, with Rubric Capital Management LP increasing its voting rights in the company. The acquisition of additional voting rights and financial instruments by Rubric Capital Management LP signifies a strengthened position in Indivior, potentially impacting the company’s governance and strategic decisions.
More about Indivior
Indivior PLC is a UK-based pharmaceutical company that specializes in the development and commercialization of medications for the treatment of addiction and related mental health disorders. The company focuses on providing innovative treatment options to address the global addiction crisis.
YTD Price Performance: -27.73%
Average Trading Volume: 338,344
Technical Sentiment Signal: Strong Buy
Current Market Cap: £896.4M
See more insights into INDV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue